Medical/Pharmaceuticals

Sino Group and the Ng Teng Fong Charitable Foundation Launch 'Community Care Chinese Medicine Service' with Hong Kong Baptist University to Support the Well-Being of the Underprivileged

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- Sino Group (the 'Group'), the Ng Teng Fong Charitable Foundation ('NTFCF'), and the School of Chinese Medicine at Hong KongBaptist University ('HKBU') are committed to the well-being of underprivileged members of the community and have recently launched th...

2025-01-24 21:27 6099

Professor Tinly Wong Tin-Chee Pre- and Post-Exercise Care Tips from a Traditional Chinese Medicine Perspective

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- The annual Hong Kong Marathon is just around the corner, and runners are actively preparing. In addition to physical training, proper warm-ups before the race and recovery after are equally important. Professor Tinly Wong Tin-Chee, founder of Herbalgy Phar...

2025-01-24 18:00 4211

NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

Using DNA barcoding, the novel technique tracks and optimises gold nanoparticles for precise drug delivery to tumours, advancing cancer therapies that are safer and more effective SINGAPORE, Jan. 24, 2025 /PRNewswire/ -- A team of researchers from the National University of Singapore (NUS) has d...

2025-01-24 15:55 3300

Kexing Biopharm Participates in the 17th Biotech Showcase, with Multiple Innovation Pipelines Gaining Attention

SHENZHEN, China, Jan. 24, 2025 /PRNewswire/ -- From January 13 to 16, Dr. Huiming Li, Deputy General Manager of Kexing Biopharm New Drug Research Center, attended the 17th Biotech Showcase Conference inSan Francisco and the Global Biopharma Symposium hosted by Jones Day & MSQ Ventures. The Jones...

2025-01-24 14:59 3321

Datasea Announces Continued Expansion with Agreements to Place its Acoustic High-Tech Products in an Additional 200 Beauty Stores in Northern China

With the New Agreements, Products to be Placed in a Total of 463 New Stores with  Total Projected Sales of 260,000 Units and Revenue of $19 Million  Expected by Year End 2025 BEIJING, Jan. 23, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS), a Nevada -based digital technology company specializing...

2025-01-23 22:30 4519

Lunit AI Enhances Precision in Predicting Outcomes for HER2-Targeted Therapy in Metastatic Colorectal Cancer - new study published in JCO Precision Oncology

Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor microenvironment analysis improves patient stratification and clinical outcome predictions SEOUL, South Korea, Jan. 23, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered sol...

2025-01-23 22:00 4250

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built inChina th...

2025-01-23 20:35 3729

European Wellness Biomedical Group (EWBG) Partners with Toviyah Life to Unveil Cutting-Edge Health Technology

KOTA KINABALU, Malaysia, Jan. 23, 2025 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG) and Toviyah Life Pte Ltd (Toviyah) have announced a new partnership aimed at improving wellness through a handheld device called BeLight. The two companies signed a Memorandum of Understanding (MO...

2025-01-23 16:45 4678

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization inChina from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed innovativ...

2025-01-23 13:44 3564

GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC

YONGIN, South Korea, Jan. 23, 2025 /PRNewswire/ -- GC Cell , a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized in collaboration with PT Bifarma Ad...

2025-01-23 09:30 2829

Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature Medicine

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce that the prestigious medical journal Nature Medicine published the results of the company's independently developed PD-1/CTLA-4 bispecific antibody cadonilimab in combination with oxali...

2025-01-23 08:31 2544

Sunway Medical Centre named in the inaugural Newsweek's Asia's Top Private Hospitals 2025 ranking

SUBANG JAYA, Malaysia, Jan. 23, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC), has been honoured in the inaugural Newsweek's Top Private Hospitals 2025ranking and recognised as the top hospital in Malaysia for four out of five procedures: knee surgery and knee replacement, shoulde...

2025-01-23 07:28 3711

deCODE genetics: Complete recombination map of the human-genome, a major step in genetics

REYKJAVIK, Iceland, Jan. 23, 2025 /PRNewswire/ -- Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic diversity and its impact on health and fertility. It...

2025-01-23 00:00 3651

Forum 30: Advancing Global Standards for Medical Products of Human Origin

REDLANDS, Calif., Jan. 22, 2025 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authority for bloodCentro Nazionale Sangue ("CNS") and for cells/tissuesCentro Nazionale Trapianti ("CNT"), hosted F...

2025-01-22 23:54 2479

TraceLink Named to the 2025 RXinsider Pharmacy500 List for Excellence in Pharmacy Supply Chain Innovation

TraceLink recognized for advancing digitalization and orchestration in the pharmacy supply chain, ensuring safe and timely access to medications BOSTON, Jan. 22, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, is honored ...

2025-01-22 23:00 2731

GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy

SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ -- GI Innovation  (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy.

2025-01-22 21:00 3357

L&C Bio Secures World's First NMPA Approval for 'MegaDerm Plus' in China

SEONGNAM-SI, South Korea, Jan. 22, 2025 /PRNewswire/ -- L&C Bio (CEO Hwan-Chul Lee) has achieved a significant milestone in its global market strategy by becoming the first company worldwide to secure approval fromChina's National Medical Products Administration (NMPA) for its acellular dermal ma...

2025-01-22 20:30 3113

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology. TAIPEI, Jan. 22, 2025 /PRNewswire/ -- JelloX

2025-01-22 15:29 3294

Samsung Biologics reports fourth quarter and fiscal year 2024 financial results

* Recorded Q4'24 consolidated revenue of KRW 1.26 trillion * Recorded FY'24 consolidated revenue of KRW 4.55 trillion * Poised for further growth with expanded capacity and new service offerings INCHEON,South Korea, Jan. 22, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a globa...

2025-01-22 15:06 2710

Akeso Received Payment for the Development Collaboration on Tagitanlimab

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. ("Sichuan Kelun") for their collaboration on the development of tagitanlimab, an innovative humanized monoclona...

2025-01-22 14:57 3588
1 ... 128129130131132133134 ... 646

Week's Top Stories